Evidence map›Paper›PMID 34428256›Full record

ArticlePloS one2021

Interactome analysis of Bag-1 isoforms reveals novel interaction partners in endoplasmic reticulum-associated degradation.

Nisan Denizce Can, Ezgi Basturk, Tugba Kizilboga, Izzet Mehmet Akcay, Baran Dingiloglu, Ozge Tatli, Sevilay Acar, Pelin Ozfiliz Kilbas, Efe Elbeyli, Serena Muratcioglu and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Nisan Denizce CanDepartment of Molecular Biology-Genetics and Biotechnology, Istanbul Technical University, Istanbul, Turkey.
Ezgi BasturkDepartment of Molecular Biology-Genetics and Biotechnology, Istanbul Technical University, Istanbul, Turkey.ORCID 0000-0001-6797-4684
Tugba KizilbogaDepartment of Molecular Biology-Genetics and Biotechnology, Istanbul Technical University, Istanbul, Turkey.
Izzet Mehmet AkcayDepartment of Molecular Biology-Genetics and Biotechnology, Istanbul Technical University, Istanbul, Turkey.
Baran DingilogluDepartment of Molecular Biology-Genetics and Biotechnology, Istanbul Technical University, Istanbul, Turkey.
Ozge TatliDepartment of Molecular Biology-Genetics and Biotechnology, Istanbul Technical University, Istanbul, Turkey.
Sevilay AcarDepartment of Molecular Biology-Genetics and Biotechnology, Istanbul Technical University, Istanbul, Turkey.
Pelin Ozfiliz KilbasDepartment of Molecular Biology-Genetics and Biotechnology, Istanbul Technical University, Istanbul, Turkey.
Efe ElbeyliDepartment of Chemical and Biological Engineering, Koc University, Istanbul, Turkey.
Serena MuratciogluDepartment of Chemical and Biological Engineering, Koc University, Istanbul, Turkey.
Ayse Tarbin JannuzziFaculty of Pharmacy, Department of Pharmaceutical Toxicology, Istanbul University, Istanbul, Turkey.
Attila GursoyDepartment of Chemical and Biological Engineering, Koc University, Istanbul, Turkey.
Ozlem KeskinDepartment of Chemical and Biological Engineering, Koc University, Istanbul, Turkey.
Hamdi Levent DoganayGLAB, Umraniye Teaching and Research Hospital, Istanbul, Turkey.
Betul Karademir YilmazDepartment of Biochemistry, School of Medicine/Genetic and Metabolic Diseases Research and Investigation Center, Marmara University, Istanbul, Turkey.
Gizem Dinler DoganayDepartment of Molecular Biology-Genetics and Biotechnology, Istanbul Technical University, Istanbul, Turkey.ORCID 0000-0002-3586-1287
Istanbul Technical University · TRKoç University · TRIstanbul Kültür University · TRIstanbul University · TRMarmara University · TRÜmraniye Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bag-1 is a multifunctional protein that regulates Hsp70 chaperone activity, apoptosis, and proliferation. The three major Bag-1 isoforms have different subcellular localizations and partly non-overlapping functions. To identify the detailed interaction network of each isoform, we utilized mass spectrometry-based proteomics and found that interactomes of Bag-1 isoforms contained many common proteins, with variations in their abundances. Bag-1 interactomes were enriched with proteins involved in protein processing and degradation pathways. Novel interaction partners included VCP/p97; a transitional ER ATPase, Rad23B; a shuttling factor for ubiquitinated proteins, proteasome components, and ER-resident proteins, suggesting a role for Bag-1 also in ER-associated protein degradation (ERAD). Bag-1 pull-down from cells and tissues from breast cancer patients validated these interactions and showed cancer-related prominence. Using in silico predictions we detected hotspot residues of Bag-1. Mutations of these residues caused loss of binding to protein quality control elements and impaired proteasomal activity in MCF-7 cells. Following CD147 glycosylation pattern, we showed that Bag-1 downregulated VCP/p97-dependent ERAD. Overall, our data extends the interaction map of Bag-1, and broadens its role in protein homeostasis. Targeting the interaction surfaces revealed in this study might be an effective strategy in the treatment of cancer.

Indexed as

Endoplasmic Reticulum-Associated DegradationBasiginDNA-Binding ProteinsEndoplasmic ReticulumHumansMCF-7 CellsProteasome Endopeptidase ComplexProtein IsoformsTranscription FactorsValosin Containing ProteinBasiginBCL2-associated athanogene 1 proteinBSG protein, humanDNA-Binding ProteinsProteasome Endopeptidase ComplexProtein IsoformsTranscription FactorsValosin Containing ProteinVCP protein, human

Identifiers

PMID34428256
PMCPMC8384158
OpenAlexW3195612260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.